Clinical Trial Update: Early-onset Dupilumab Effects in CRSwNP [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating early-onset dupilumab in chronic rhinosinusitis with nasal polyps has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: University of Rochester | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 4 | Status: WITHDRAWN